Cargando…
MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk
The ‘onco-receptor’ MET (Hepatocyte Growth Factor Receptor) is involved in the activation of the invasive growth program that is essential during embryonic development and critical for wound healing and organ regeneration during adult life. When aberrantly activated, MET and its stroma-secreted liga...
Autores principales: | Modica, Chiara, Tortarolo, Dora, Comoglio, Paolo M., Basilico, Cristina, Vigna, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321305/ https://www.ncbi.nlm.nih.gov/pubmed/30544501 http://dx.doi.org/10.3390/ijms19123920 |
Ejemplares similares
-
HGF/MET Axis Induces Tumor Secretion of Tenascin-C and Promotes Stromal Rewiring in Pancreatic Cancer
por: Modica, Chiara, et al.
Publicado: (2021) -
A receptor-antibody hybrid hampering MET-driven metastatic spread
por: Modica, Chiara, et al.
Publicado: (2021) -
Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination
por: Modica, Chiara, et al.
Publicado: (2023) -
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
por: Modica, Chiara, et al.
Publicado: (2020) -
hOA-DN30: a highly effective humanized single-arm MET antibody inducing remission of ‘MET-addicted’ cancers
por: Martinelli, Ilaria, et al.
Publicado: (2022)